Autoplaque vs BodyGuardian Remote Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

BodyGuardian Remote Monitoring System

by Boston Scientific Cardiac Diagnostics

AI Verdict

Tool A, Autoplaque, specializes in AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images for heart attack risk prediction. Conversely, Tool B, BodyGuardian Remote Monitoring System, is a wearable device that uses AI to continuously monitor and detect non-lethal cardiac arrhythmias from physiological data. While both leverage AI in cardiology, they address distinct clinical needs and utilize different data modalities and deployment methods.

Choose Autoplaque if…

Choose Autoplaque if your primary need is a detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for clinicians seeking to enhance heart attack risk prediction and guide treatment strategies based on precise anatomical and pathological insights from cardiac CT scans. It provides a workstation-based solution for in-depth post-processing and review of coronary artery disease.

View Autoplaque →

Choose BodyGuardian Remote Monitoring System if…

Choose the BodyGuardian Remote Monitoring System if you require continuous, ambulatory monitoring of patients for the detection and management of non-lethal cardiac arrhythmias. This wearable device is best suited for remotely collecting physiological data like ECG, heart rate, and respiration, enabling timely intervention for transient or infrequent cardiac events outside of a clinical setting. It offers a comprehensive solution for long-term cardiac surveillance with integrated AI analytics.

View BodyGuardian Remote Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	BodyGuardian Remote Monitoring System
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	Cloud-based platform with EMR integration.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BodyGuardian Remote Monitoring System

BodyGuardian offers a more flexible and patient-centric usability experience with its wearable design, mobile app, and cloud-based platform for continuous monitoring. Autoplaque, while offering clinician-editable automated analysis, is limited to a workstation environment. The waterproof and comfortable design of BodyGuardian also enhances patient compliance and ease of use in daily life.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in distinct areas of cardiology. Autoplaque offers crucial insights into heart attack risk prediction through advanced plaque analysis, while BodyGuardian provides comprehensive, continuous, and multi-modal arrhythmia detection for ambulatory patients. Both have supporting clinical validation demonstrating their effectiveness in improving diagnostic capabilities and guiding treatment.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, making a direct comparison of their pricing and value proposition impossible. Both require contacting the vendor for details, which limits transparency for potential buyers.

Enterprise Readiness

BodyGuardian Remote Monitoring System

BodyGuardian explicitly states HIPAA compliance and implies a Business Associate Agreement (BAA), which are critical for healthcare enterprise operations. Its cloud-based platform and wide range of EMR integrations also indicate a more scalable and integrated solution, enhancing its readiness for enterprise-level deployment compared to Autoplaque's workstation-based model and unspecified compliance.

Innovation

BodyGuardian Remote Monitoring System

BodyGuardian demonstrates broader innovation by integrating multiple cardiac monitoring modalities into a single, comfortable wearable device with continuous wireless data transmission and deep learning AI for rhythm analysis. This comprehensive approach to remote patient monitoring, combining hardware and advanced analytics, offers a more expansive innovative solution than Autoplaque's specialized image analysis software.

Support & Docs

BodyGuardian Remote Monitoring System

BodyGuardian provides extensive and easily accessible support for both patients and physicians, including 24/7 customer service, comprehensive patient resources, and detailed physician FAQs covering various aspects from usage to reimbursement. Autoplaque's documentation mentions a user manual and contacting support, but lacks the breadth and accessibility of BodyGuardian's support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	BodyGuardian Remote Monitoring System
Primary Function	AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	A wearable device that collects and transmits physiological data for the detection and monitoring of non-lethal cardiac arrhythmias in ambulatory patients, integrating multiple monitoring technologies and AI-powered analytics.
Company	Cedars-Sinai Medical Center: AIM	Preventice Technologies (now Boston Scientific Cardiac Diagnostics)
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Radiology	Cardiology, Pediatrics
Core Analysis/Monitoring Focus	Quantitative analysis of atherosclerotic plaque and luminal stenoses from CT Angiographic images	Detection and monitoring of non-lethal cardiac arrhythmias; collects ECG, heart rate, respiration rate, and activity level data
AI Component Details	AI-powered quantitative analysis of atherosclerotic plaque	Sophisticated algorithms, including BeatLogic deep learning AI for accurate rhythm analysis

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and BodyGuardian Remote Monitoring System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do Autoplaque and BodyGuardian integrate into distinct clinical workflows and which specific specialties are best served by each tool?

Autoplaque is a workstation-based post-processing application for CT angiography images, primarily benefiting Cardiology and Radiology by aiding in heart attack risk prediction and treatment guidance through quantitative plaque analysis. BodyGuardian is a wearable remote monitoring system for ambulatory patients, collecting physiological data for detecting non-lethal cardiac arrhythmias, making it suitable for Cardiology and Pediatrics.

Can you elaborate on the accuracy and sensitivity of the AI algorithms used in each tool for their respective diagnostic purposes?

Autoplaque utilizes AI for quantitative analysis, enabling automated vessel, plaque, and lumen segmentation from CT angiography images, which clinicians can review and edit for accuracy in plaque and stenosis measurement. BodyGuardian employs sophisticated algorithms, including BeatLogic deep learning AI, for accurate rhythm analysis in detecting and monitoring non-lethal cardiac arrhythmias from continuous ECG, heart rate, respiration rate, and activity level data, with studies showing high beat detection sensitivity and positive predictive value.

How do clinicians interact with and review the data generated by Autoplaque and BodyGuardian?

With Autoplaque, clinicians review heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views, with the ability to review and edit automated vessel, plaque, and lumen segmentations. For BodyGuardian, physicians review collected physiological data via a web portal or a dedicated mobile application, such as an iPad app, after wireless transmission from the wearable device to a cloud-based platform.

What are the key considerations for time-to-value and implementation for a practice adopting either Autoplaque or BodyGuardian?

Autoplaque is a workstation-based software, suggesting an implementation focused on integrating the software into existing imaging workflows and training staff on its post-processing application. BodyGuardian involves a wearable device, mobile application, and cloud-based platform, implying a time-to-value related to patient onboarding, device distribution, and familiarization with the remote monitoring web portal, with a reported 24-48 hour average report turnaround.

What audit-trail features are available to ensure data integrity and accountability within each system?

Autoplaque's automated vessel, plaque, and lumen segmentations are reviewable and editable by clinicians, implying a mechanism to track changes made to the analysis. BodyGuardian's system is designed to not miss data and can store up to 24 hours of data on the device itself, with data then transmitted to a cloud for later review by medical staff, suggesting robust data logging for integrity.

What level of integration can be expected with existing Electronic Health Record (EHR) systems for both tools?

Autoplaque's description does not explicitly detail EHR integration depth. BodyGuardian offers a wide range of EMR integrations, with a field-based team dedicated to integration and workflow optimization, and capabilities for discrete data elements integration via orders and results interface.